SLU-PP-332

Experimental Exercise Mimetic | Metabolic Research Compound

Product Overview

SLU-PP-332, also known as SLUPP, is an experimental small-molecule compound being investigated for its potential effects on energy metabolism, fat oxidation, and skeletal muscle endurance.

Often described as an “exercise mimetic,” SLU-PP-332 is a synthetic agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ, which play important roles in mitochondrial function, cellular energy regulation, and oxidative metabolism.

Unlike conventional stimulants, SLU-PP-332 targets metabolic pathways associated with aerobic exercise, making it an emerging subject of interest in preclinical metabolic research.

Mechanism of Action

SLU-PP-332 activates estrogen-related receptor signaling pathways involved in regulating cellular energy production and metabolic adaptation.

Preclinical research suggests that this activation may:

• Enhance oxidative metabolism: Promote pathways involved in mitochondrial energy production.

• Increase fat oxidation: Support greater utilization of fatty acids as an energy source in experimental models.

• Improve muscular endurance: Influence skeletal muscle metabolism in ways associated with aerobic training adaptations.

• Increase energy expenditure: Activate metabolic processes associated with higher energy consumption.

• Support metabolic research: Provide a potential research pathway for investigating obesity, metabolic dysfunction, and muscle-related conditions.

These effects have been investigated in preclinical models and have not been established in humans.

Preclinical Research Findings

Animal studies investigating SLU-PP-332 have reported promising results, including:

• Approximately 12% reduction in fat mass in certain obese mouse models over a four-week period.

• Nearly 50% improvement in endurance performance under specific experimental conditions.

• Improved glucose tolerance and metabolic parameters in studied animals.

• Enhanced skeletal muscle oxidative metabolism, suggesting adaptations resembling certain effects of endurance exercise.

Important: These findings are based on animal experiments. They should not be interpreted as evidence of equivalent benefits in humans.

Research Applications

SLU-PP-332 is being investigated in research involving:

• Estrogen-related receptor signaling

• Mitochondrial function and energy metabolism

• Skeletal muscle oxidative adaptations

• Obesity and metabolic dysfunction

• Exercise-mimetic pharmacology

• Glucose homeostasis and fatty acid metabolism

Safety & Regulatory Status

SLU-PP-332 is an experimental research compound and is not approved for human consumption or therapeutic use.

Human clinical safety and efficacy have not been established. Its toxicity profile, pharmacokinetics, appropriate dosing, potential adverse effects, and long-term consequences in humans remain insufficiently characterized.

Animal research does not establish that SLU-PP-332 can safely replace physical exercise. Exercise provides additional cardiovascular, skeletal, psychological, and physiological benefits that have not been demonstrated with this compound.

Research Use Only

FOR LABORATORY RESEARCH PURPOSES ONLY.

Intended exclusively for qualified professionals conducting legitimate scientific investigations.

Not for human or veterinary use. Not for ingestion, injection, or self-administration. Not intended to diagnose, treat, cure, or prevent any disease.

PEPTITAN — Precision. Science. Research.